Correction: Ferdowsi et al. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861
- Figure 1. Insulin signal transduction. Insulin binding to its receptor’s extracellular α subunit causes a conformational change in the β subunit of the receptor, which eventually triggers phosphorylation (designated as P) of intracellular proteins, IRSs, which further activates insulin-mediated downstream events including phosphorylation of signalling proteins PI3K, PIP3, AKT, and AS160, leading to GLUT4 movement and glucose disposal.
- Figure 2. Pathophysiology of T2DM. Several factors can lead to the development of Type 2 Diabetes Mellitus. These include environmental factors such as lifestyle (physical inactivity, diet, etc), and genetics. These factors can contribute to insulin resistance in muscle, adipose, and liver. Insulin resistance is the precursor to beta cell dysfunction, impaired glucose tolerance, and the development of Type 2 Diabetes Mellitus.
- Figure 3. CAMK pathway and the downstream signalling events following TRPV1 activation by capsaicin. Activation of the TRPV1 channel by capsaicin triggers an elevation in calcium flux to the cytosol, which initiates calcium signal transduction in the skeletal muscle cell. Calcium binding to CAM induces a structural modification in CAM and forms a calcium/calmodulin complex. This complex controls the activity of CAMKKs and AMPK, which accordingly stimulate signalling events leading to glucose uptake, including CREB and TORCs activation, and the translocation of Glut4 receptors.
Reference
- Ferdowsi, P.V.; Ahuja, K.D.K.; Beckett, J.M.; Myers, S. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ferdowsi, P.V.; Ahuja, K.D.K.; Beckett, J.M.; Myers, S. Correction: Ferdowsi et al. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861. Molecules 2025, 30, 1446. https://doi.org/10.3390/molecules30071446
Ferdowsi PV, Ahuja KDK, Beckett JM, Myers S. Correction: Ferdowsi et al. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861. Molecules. 2025; 30(7):1446. https://doi.org/10.3390/molecules30071446
Chicago/Turabian StyleFerdowsi, Parisa Vahidi, Kiran D. K. Ahuja, Jeffrey M. Beckett, and Stephen Myers. 2025. "Correction: Ferdowsi et al. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861" Molecules 30, no. 7: 1446. https://doi.org/10.3390/molecules30071446
APA StyleFerdowsi, P. V., Ahuja, K. D. K., Beckett, J. M., & Myers, S. (2025). Correction: Ferdowsi et al. Capsaicin and Zinc Signalling Pathways as Promising Targets for Managing Insulin Resistance and Type 2 Diabetes. Molecules 2023, 28, 2861. Molecules, 30(7), 1446. https://doi.org/10.3390/molecules30071446